Morningside Venture Investments Ltd Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Morningside Venture Investments Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Morningside Venture Investments Ltd. Morningside Venture Investments Ltd is 10% Owner in Liquidia Technologies Inc ($LQDA) and 10% Owner in Apellis Pharmaceuticals, Inc. ($APLS) and 10% Owner in Kezar Life Sciences, Inc. ($KZR).
Latest Insider Trading Transactions of Morningside Venture Investments Ltd
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APLS, KZR, LIQDA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 06 2020 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Buy | P | 2.60 | 3,800,000 | 9,880,000 | 6,109,052 | 2.3 M to 6.1 M (+164.57 %) |
Jan 21 2020 | APLS | Apellis Pharmaceut ... | Morningside Venture Investment ... | 10% Owner | Buy | P | 37.00 | 540,540 | 19,999,980 | 12,556,342 | 12 M to 12.6 M (+4.50 %) |
Mar 13 2019 | APLS | Apellis Pharmaceut ... | Morningside Venture Investment ... | 10% Owner | Buy | P | 17.00 | 441,176 | 7,499,992 | 12,015,802 | 11.6 M to 12 M (+3.81 %) |
Sep 24 2018 | APLS | Apellis Pharmaceut ... | Morningside Venture Investment ... | 10% Owner | Buy | P | 19.84 | 40,000 | 793,600 | 11,574,626 | 11.5 M to 11.6 M (+0.35 %) |
Sep 24 2018 | APLS | Apellis Pharmaceut ... | Morningside Venture Investment ... | 10% Owner | Buy | P | 19.43 | 21,724 | 422,097 | 11,534,626 | 11.5 M to 11.5 M (+0.19 %) |
Sep 24 2018 | APLS | Apellis Pharmaceut ... | Morningside Venture Investment ... | 10% Owner | Buy | P | 18.79 | 19,599 | 368,265 | 11,512,902 | 11.5 M to 11.5 M (+0.17 %) |
Sep 19 2018 | APLS | Apellis Pharmaceut ... | Morningside Venture Investment ... | 10% Owner | Buy | P | 18.09 | 60,000 | 1,085,400 | 11,493,303 | 11.4 M to 11.5 M (+0.52 %) |
Sep 19 2018 | APLS | Apellis Pharmaceut ... | Morningside Venture Investment ... | 10% Owner | Buy | P | 18.47 | 40,000 | 738,800 | 11,433,303 | 11.4 M to 11.4 M (+0.35 %) |
Sep 19 2018 | APLS | Apellis Pharmaceut ... | Morningside Venture Investment ... | 10% Owner | Buy | P | 18.84 | 8,600 | 162,024 | 11,393,303 | 11.4 M to 11.4 M (+0.08 %) |
Sep 19 2018 | APLS | Apellis Pharmaceut ... | Morningside Venture Investment ... | 10% Owner | Buy | P | 18.50 | 31,400 | 580,900 | 11,384,703 | 11.4 M to 11.4 M (+0.28 %) |
Aug 01 2018 | LQDA | Liquidia Technolog ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | J | 0.01 | 18,996 | 190 | 18,996 | |
Aug 01 2018 | LQDA | Liquidia Technolog ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | J | 0.01 | 319,664 | 3,197 | 0 | |
Aug 01 2018 | LQDA | Liquidia Technolog ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | C | 0.00 | 1,849,490 | 0 | 0 | |
Aug 01 2018 | LQDA | Liquidia Technolog ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | C | 0.00 | 3,420,516 | 0 | 0 | |
Aug 01 2018 | LQDA | Liquidia Technolog ... | Morningside Venture Investment ... | 10% Owner | Buy | C | 0.00 | 109,909 | 0 | 552,728 | 442.8 K to 552.7 K (+24.82 %) |
Aug 01 2018 | LQDA | Liquidia Technolog ... | Morningside Venture Investment ... | 10% Owner | Buy | C | 0.00 | 442,819 | 0 | 442,819 | 0 to 442.8 K |
Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | C | 0.00 | 1,007,422 | 0 | 0 | |
Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | C | 0.00 | 1,051,630 | 0 | 0 | |
Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Buy | P | 15.00 | 250,000 | 3,750,000 | 2,309,052 | 2.1 M to 2.3 M (+12.14 %) |
Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Buy | C | 0.00 | 1,007,422 | 0 | 2,059,052 | 1.1 M to 2.1 M (+95.80 %) |
Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Buy | C | 0.00 | 1,051,630 | 0 | 1,051,630 | 0 to 1.1 M |
Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | C | 0.00 | 1,007,422 | 0 | 0 | |
Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | C | 0.00 | 1,051,630 | 0 | 0 | |
Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Buy | P | 15.00 | 250,000 | 3,750,000 | 2,309,052 | 2.1 M to 2.3 M (+12.14 %) |
Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Buy | C | 0.00 | 1,007,422 | 0 | 2,059,052 | 1.1 M to 2.1 M (+95.80 %) |
Jun 27 2018 | KZR | Kezar Life Science ... | Morningside Venture Investment ... | 10% Owner | Buy | C | 0.00 | 1,051,630 | 0 | 1,051,630 | 0 to 1.1 M |
Nov 13 2017 | APLS | Apellis Pharmaceut ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | C | 0.00 | 259,302 | 0 | 0 | |
Nov 13 2017 | APLS | Apellis Pharmaceut ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | C | 0.00 | 4,476,275 | 0 | 0 | |
Nov 13 2017 | APLS | Apellis Pharmaceut ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | C | 0.00 | 17,200,000 | 0 | 0 | |
Nov 13 2017 | APLS | Apellis Pharmaceut ... | Morningside Venture Investment ... | 10% Owner | Option Exercise | C | 0.00 | 1,054,544 | 0 | 0 | |
Nov 13 2017 | APLS | Apellis Pharmaceut ... | Morningside Venture Investment ... | 10% Owner | Buy | P | 14.00 | 575,000 | 8,050,000 | 11,353,303 | 10.8 M to 11.4 M (+5.33 %) |
Nov 13 2017 | APLS | Apellis Pharmaceut ... | Morningside Venture Investment ... | 10% Owner | Buy | C | 0.00 | 10,778,303 | 0 | 10,778,303 | 0 to 10.8 M |
Page: 1